Skip to main content
logo
DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
6.39
-0.36 (-5.33%)
Aug 28, 2026, 4:00 PM EDT - Market closed

DiaMedica Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-39.23-34.4-26.68-21.27-14-13.65
Net Income
-37.54-32.77-24.44-19.38-13.68-13.59
Earnings Per Share
-0.72-0.70-0.60-0.60-0.52-0.65
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
43.559.8944.1552.933.545.11
Total Debt
0.190.240.340.40.470.05
Net Cash (Debt)
43.3259.6543.8152.533.0345.06
Net Cash Growth
45.63%36.17%-16.55%58.92%-26.69%64.52%
Net Cash Per Share
0.831.271.081.611.252.17

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-31.51-29.06-22.08-18.73-11.51-12.25
Capital Expenditures
-0.03-0.04-0.03-0.02-0.08-0.02
Free Cash Flow
-31.54-29.1-22.1-18.75-11.59-12.27
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
------